Literature DB >> 17223052

Treatment with piperacillin-tazobactam and Aspergillus galactomannan test results for patients with hematological malignancies.

Fahir Ozkalemkas1, Tulay Ozcelik, Vildan Ozkocaman.   

Abstract

Entities:  

Year:  2007        PMID： 17223052     DOI： 10.1016/j.ejim.2006.05.006

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN： 0953-6205            Impact factor:   4.487


× No keyword cloud information.
  2 in total

1.  The interaction between piperacillin/tazobactam and assays for Aspergillus galactomannan and 1,3-beta-D-glucan in patients without risk factors for invasive fungal infections.

Authors:  G Metan; C Ağkuş; H Buldu; A N Koç
Journal:  Infection       Date:  2010-03-17       Impact factor: 3.553

2.  Factors influencing the early mortality in haematological malignancy patients with nosocomial Gram negative bacilli bacteraemia: a retrospective analysis of 154 cases.

Authors:  Gökhan Metan; Hayati Demiraslan; Leyla Gül Kaynar; Gökmen Zararsız; Emine Alp; Bülent Eser
Journal:  Braz J Infect Dis       Date:  2013-02-26       Impact factor: 3.257
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.